iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival 
Trade Compliance Records Addresses June 2026 Executive Order Broker Liability 
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth 
Central Asia visit drives multi-sector collaboration, Business delegation signed 66 MoUs and agreements to seize Belt and Road opportunities 
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments
Alliance for Regenerative Medicine Supports the Council Position on EU Joint Clinical Assessments European Patients…
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical…
HUTCHMED Enters Agreement to Divest Non-Core OTC Joint Venture for US$169 Million
Allows focus on China and global clinical development and market launches of key Oncology/Immunology assets HONG…
AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,”…
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:…
ORYZON Publishes Vafidemstat First-in-Human Clinical Trial Manuscript in CNS Drugs Journal
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers Paper confirms vafidemstat…
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX…
Praxis Precision Medicines to Present at Stifel’s 3rd Annual CNS Day
CAMBRIDGE, Mass., March 24, 2021 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a…
I-Mab to Host 2021 R&D Day
Mandarin session on April 7, 2021 and English session on April 26, 2021 for investors…
CytomX Therapeutics to Host Virtual Investor Event on April 7, 2021
SOUTH SAN FRANCISCO, Calif., March 24, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a…
Beyond Air® to Present Abstracts at the American Thoracic Society Virtual Sessions in May 2021
GARDEN CITY, N.Y., March 24, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
REN001 Granted Fast Track Designation by FDA for Patients with Primary Mitochondrial Myopathies
SAN DIEGO, March 24, 2021 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical…
Radius Health Provides Update on Abaloparatide
Regulatory success achieved in Japan by partner Teijin Pharma Limited Ostabaro® approved for treatment of…
Auris Medical to Report Second Half and Full Year 2020 Financial Results and Provide Business Update on Wednesday, March 31, 2021
Hamilton, Bermuda, March 24, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company…
Theratechnologies Announces First Patient Dosed in Phase 1 Clinical Trial of TH1902 for Sortilin Positive Solid Tumors
MONTREAL, March 24, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
Abcam Wins Industry Awards from CiteAb
CAMBRIDGE, United Kingdom, March 24, 2021 (GLOBE NEWSWIRE) — Today Abcam (AIM:ABC; NASDAQ:ABCM), a global…
Embrace the Unexpected: Kolab Project Launches First Cannabis Concentrate with 232 Series Diamonds
Kolab Project 232 Series Diamonds High-potency Kolab Project 232 Series Diamonds. Kolab Project 232 Series…
ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials
QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity…
Crinetics Pharmaceuticals to Host Webcast and Conference Call to Discuss 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results
Webcast and conference call to take place on Tuesday, March 30, 2021 at 4:30 p.m….
IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021
MOUNTAIN VIEW, Calif., March 24, 2021 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage…